UTIs in Chronic Health Situations


UTIs in Chronic Health Situations


Mohiuddin AK

Dr. M. Nasirullah Memorial Trust, Tejgaon, Dhaka 1215, Bangladesh


Global Journal of Urology and Nephrology

UTIs are a severe public health problem and are caused by a range of pathogens, but most commonly by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterococcus faecalis and Staphylococcus saprophyticus. High recurrence rates and increasing antimicrobial resistance among uropathogens threaten to greatly increase the economic burden of these infections. UTIs typically occur when bacteria enter the urinary tract through the urethra and begin to multiply in the bladder. Although the urinary system is designed to keep out such microscopic invaders, these defenses sometimes fail. If left untreated, a urinary tract infection can have serious consequences. Adult women are 30 times more likely than men to develop a UTI, with almost half of them experiencing at least one episode of UTI during their lifetime. Uncomplicated lower UTI remains one of the most commonly treated infections in primary care. A complicated UTI is an infection associated with a condition, such as a structural or functional abnormality of the genitourinary tract, or the presence of an underlying disease. Diagnosis of a UTI is based on a focused history, with appropriate investigations depending on individual risk factors. The paper reviews several chronic conditions that are risk factors for UTIs in human being.


Keywords: complicated and uncomplicated UTIs; asymptomatic bacteriuria; UTIs among obese and heart patients; UTIs among renal and hepatic insufficiency; pregnancy induced complications; urinary infections among HIV and other STDs

Free Full-text PDF


How to cite this article:
Mohiuddin AK. UTIs in Chronic Health Situations. Global Journal of Urology and Nephrology, 2019, 2:18. DOI: 10.28933/gjun-2019-10-1805


References:

1. Mohiuddin AK. Lifestyle Issues and Prevention of Recurrent UTIs. Biomedical Journal of Scientific & Technical Research. 2019;21(3). doi:10.26717/bjstr.2019.21.003618.
2. Mohiuddin AK. Lifestyle Issues and Prevention of Recurrent UTIs. International Research in Medical and Health Science. April 2019. doi: https://doi.org/10.36437/irmhs.2019.2.4.S.
3. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015 May;13(5):269-84. doi: 10.1038/nrmicro3432.
4. Mohiuddin AK. Alternative Management of Uncomplicated UTIs in Women. Journal of Gynecology and Womens Health. 2019;16(1):1-5. doi:10.19080/jgwh.2019.14.555930.
5. Woldemariam HK, Geleta DA, Tulu KD, Aber NA, Legese MH, Fenta GM, Ali I. Common uropathogens and their antibiotic susceptibility pattern among diabetic patients. BMC Infect Dis. 2019 Jan 10;19(1):43. doi: 10.1186/s12879-018-3669-5.
6. Odoki M, Almustapha Aliero A, Tibyangye J, et al. Prevalence of Bacterial Urinary Tract Infections and Associated Factors among Patients Attending Hospitals in Bushenyi District, Uganda. Int J Microbiol. 2019;2019:4246780. Published 2019 Feb 17. doi:10.1155/2019/4246780
7. Medina M, Castillo-Pino E. An introduction to the epidemiology and burden of urinary tract infections. Ther Adv Urol. 2019;11:1756287219832172. Published 2019 May 2. doi:10.1177/1756287219832172
8. Mohiuddin AK. TRACK Implementation among Bangladeshi Population. Int J Diabetol Vasc Dis Res. 2019;7(4):254-260. doi: dx.doi.org/10.19070/2328-353X-1900048
9. Mohiuddin AK. Diabetes Fact: Bangladesh Perspective. International Journal of Diabetes Research 2019; 2(1): 14-20. Doi: 10.17554/j.issn.2414-2409.2019.02.12
10. Mama M, Manilal A, Gezmu T, Kidanewold A, Gosa F, Gebresilasie A. Prevalence and associated factors of urinary tract infections among diabetic patients in Arba Minch Hospital, Arba Minch province, South Ethiopia. Turk J Urol. 2018;45(1):56–62. Published 2018 Nov 21. doi:10.5152/tud.2018.32855
11. Kumar R, Kumar R, Perswani P, Taimur M, Shah A, Shaukat F. Clinical and Microbiological Profile of Urinary Tract Infections in Diabetic versus Non-Diabetic Individuals. Cureus. 2019;11(8):e5464. Published 2019 Aug 22. doi:10.7759/cureus.5464
12. Bharti A, Chawla SPS, Kumar S, et al. Asymptomatic bacteriuria among the patients of type 2 diabetes mellitus. J Family Med Prim Care. 2019;8(2):539–543. doi:10.4103/jfmpc.jfmpc_403_18
13. Zubair KU, Shah AH, Fawwad A, Sabir R, Butt A. Frequency of urinary tract infection and antibiotic sensitivity of uropathogens in patients with diabetes. Pak J Med Sci. 2019;35(6):1664–1668. doi:10.12669/pjms.35.6.115
14. Matuszkiewicz-Rowińska J, Małyszko J, Wieliczko M. Urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems. Arch Med Sci. 2015;11(1):67–77. doi:10.5114/aoms.2013.39202
15. Shih WY, Chang CC, Tsou MT, Chan HL, Chen YJ, Hwang LC. Incidence and Risk Factors for Urinary Tract Infection in an Elder Home Care Population in Taiwan: A Retrospective Cohort Study. Int J Environ Res Public Health. 2019;16(4):566. Published 2019 Feb 16. doi:10.3390/ijerph16040566
16. Al-Rubeaan KA, Moharram O, Al-Naqeb D, Hassan A, Rafiullah MR. Prevalence of urinary tract infection and risk factors among Saudi patients with diabetes. World J Urol. 2013 Jun;31(3):573-8. doi: 10.1007/s00345-012-0934-x.
17. La Vignera S, Condorelli RA, Cannarella R, et al. Urogenital infections in patients with diabetes mellitus: Beyond the conventional aspects. Int J Immunopathol Pharmacol. 2019;33:2058738419866582. Published 2019 Sep 5. doi:10.1177/2058738419866582
18. Rajsic S, Gothe H, Borba HH, Sroczynski G, Vujicic J, Toell T, Siebert U. Economic burden of stroke: a systematic review on post-stroke care. Eur J Health Econ. 2019 Feb;20(1):107-134. doi: 10.1007/s10198-018-0984-0.
19. Zhang H, Yin Y, Zhang C, Zhang D. Costs of hospitalization for stroke from two urban health insurance claims data in Guangzhou City, southern China. BMC Health Serv Res. 2019;19(1):671. Published 2019 Sep 18. doi:10.1186/s12913-019-4530-2
20. Lapchak PA, Zhang JH. The High Cost of Stroke and Stroke Cytoprotection Research. Transl Stroke Res. 2017;8(4):307–317. doi:10.1007/s12975-016-0518-y
21. Ramanathan S, Reeves P, Deeming S, et al. Implementing a protocol for a research impact assessment of the Centre for Research Excellence in Stroke Rehabilitation and Brain Recovery. Health Res Policy Syst. 2018;16(1):71. Published 2018 Aug 1. doi:10.1186/s12961-018-0349-2
22. Lau LH, Lew J, Borschmann K, Thijs V, Ekinci EI. Prevalence of diabetes and its effects on stroke outcomes: A meta-analysis and literature review. J Diabetes Investig. 2019;10(3):780–792. doi:10.1111/jdi.12932
23. Wu S, Wang C, Jia Q, Liu G, Hoff K, Wang X, Wang A, Wang C, Zhao X, Wang Y, Liu L, Wang Y. HbA1c is associated with increased all-cause mortality in the first year after acute ischemic stroke. Neurol Res. 2014 May;36(5):444-52. doi: 10.1179/1743132814Y.0000000355.
24. Lim S, Oh TJ, Dawson J, Sattar N. Diabetes drugs and stroke risk: Intensive versus conventional glucose-lowering strategies, and implications of recent cardiovascular outcome trials. Diabetes Obes Metab. 2020 Jan;22(1):6-15. doi: 10.1111/dom.13850.
25. Boehme AK, Kulick ER, Canning M, et al. Infections Increase the Risk of 30-Day Readmissions Among Stroke Survivors. Stroke. 2018;49(12):2999–3005. doi:10.1161/STROKEAHA.118.022837
26. Bogason E, Morrison K, Zalatimo O, et al. Urinary Tract Infections in Hospitalized Ischemic Stroke Patients: Source and Impact on Outcome. Cureus. 2017;9(2):e1014. Published 2017 Feb 6. doi:10.7759/cureus.1014
27. Cortes-Penfield NW, Trautner BW, Jump RLP. Urinary Tract Infection and Asymptomatic Bacteriuria in Older Adults. Infect Dis Clin North Am. 2017;31(4):673–688. doi:10.1016/j.idc.2017.07.002
28. Donkor ES, Akumwena A, Amoo PK, Owolabi MO, Aspelund T, Gudnason V. Post-stroke bacteriuria among stroke patients attending a physiotherapy clinic in Ghana: a cross-sectional study. Ther Clin Risk Manag. 2016;12:457–462. Published 2016 Mar 17. doi:10.2147/TCRM.S90474
29. Poisson SN, Johnston SC, Josephson SA. Urinary tract infections complicating stroke: mechanisms, consequences, and possible solutions. Stroke. 2010 Apr;41(4):e180-4. doi: 10.1161/STROKEAHA.109.576413.
30. Net P, Karnycheff F, Vasse M, Bourdain F, Bonan B, Lapergue B. Urinary tract infection after acute stroke: Impact of indwelling urinary catheterization and assessment of catheter-use practices in French stroke centers. Rev Neurol (Paris). 2018 Mar;174(3):145-149. doi: 10.1016/j.neurol.2017.06.029.
31. Tewary K, Narchi H. Recurrent urinary tract infections in children: Preventive interventions other than prophylactic antibiotics. World J Methodol. 2015;5(2):13–19. Published 2015 Jun 26. doi:10.5662/wjm.v5.i2.13.
32. Bandari B, Sindgikar SP, Kumar SS, Vijaya MS, Shankar R. Renal scarring following urinary tract infections in children. Sudan J Paediatr. 2019;19(1):25–30. doi:10.24911/SJP.106-1554791193
33. Vachvanichsanong P. Urinary tract infection: one lingering effect of childhood kidney diseases–review of the literature. J Nephrol. 2007 Jan-Feb;20(1):21-8.
34. Schindler AE. New data about preeclampsia: some possibilities of prevention. Gynecol Endocrinol. 2018 Aug;34(8):636-637. doi: 10.1080/09513590.2018.1441401.
35. Karmon A, Sheiner E. The relationship between urinary tract infection during pregnancy and preeclampsia: causal, confounded or spurious? Arch Gynecol Obstet. 2008 Jun;277(6):479-81. doi: 10.1007/s00404-008-0643-2.
36. Yan L, Jin Y, Hang H, Yan B. The association between urinary tract infection during pregnancy and preeclampsia: A meta-analysis. Medicine (Baltimore). 2018;97(36):e12192. doi:10.1097/MD.0000000000012192
37. Urinary Tract Infections. Available From: https://www.womenshealth.gov/files/documents/fact-sheet-urinary-tract-infections.pdf
38. Rasouli M, Pourheidari M, Hamzeh Gardesh Z. Effect of Self-care Before and During Pregnancy to Prevention and Control Preeclampsia in High-risk Women. Int J Prev Med. 2019;10:21. Published 2019 Feb 12. doi:10.4103/ijpvm.IJPVM_300_17
39. Tishler M, Caspi D, Almog Y, Segal R, Yaron M. Increased incidence of urinary tract infection in patients with rheumatoid arthritis and secondary Sjögren’s syndrome. Ann Rheum Dis. 1992;51(5):604–606. doi:10.1136/ard.51.5.604
40. Ebringer A, Rashid T, Wilson C. Rheumatoid arthritis, Proteus, anti-CCP antibodies and Karl Popper. Autoimmun Rev. 2010 Feb;9(4):216-23. doi: 10.1016/j.autrev.2009.10.006.
41. Newkirk MM, Goldbach-Mansky R, Senior BW, Klippel J, Schumacher HR Jr, El-Gabalawy HS. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis. Rheumatology (Oxford). 2005 Nov;44(11):1433-41.
42. Pretorius E, Akeredolu OO, Soma P, Kell DB. Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability. Exp Biol Med (Maywood). 2017;242(4):355–373. doi:10.1177/1535370216681549
43. Rashid T, Ebringer A. Rheumatoid Arthritis is Caused by Asymptomatic Proteus Urinary Tract Infections. Clinical Management of Complicated Urinary Tract Infection. September 2011:171-180. doi:10.5772/24417.
44. Renou F, Wartel G, Raffray L, Kuli B, Fayeulle S, Yvin JL. [Reactive arthritis due to Escherichia coli urinary tract infection]. Rev Med Interne. 2011 Jan;32(1):e4-5. doi: 10.1016/j.revmed.2010.02.011.
45. Lee A, Coleman P. Escherichia coli – Marauding masquerading microbe. J Clin Orthop Trauma. 2013;4(4):194–198. doi:10.1016/j.jcot.2013.10.001
46. Youssef D, Bhargava A. Escherichia coli bacteremia with secondary seeding in the sternoclavicular joint: A case report and literature review. Germs. 2019;9(1):43–46. Published 2019 Mar 1. doi:10.18683/germs.2019.1156
47. Braga JFV, Chanteloup NK, Trotereau A, et al. Diversity of Escherichia coli strains involved in vertebral osteomyelitis and arthritis in broilers in Brazil. BMC Vet Res. 2016;12(1):140. Published 2016 Jul 14. doi:10.1186/s12917-016-0762-0
48. NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016 Apr 2;387(10026):1377-1396. doi: 10.1016/S0140-6736(16)30054-X.
49. Fruh SM. Obesity: Risk factors, complications, and strategies for sustainable long-term weight management. J Am Assoc Nurse Pract. 2017;29(S1):S3–S14. doi:10.1002/2327-6924.12510
50. Włodarczyk M, Nowicka G. Obesity, DNA Damage, and Development of Obesity-Related Diseases. Int J Mol Sci. 2019;20(5):1146. Published 2019 Mar 6. doi:10.3390/ijms20051146
51. Tsai AG, Williamson DF, Glick HA. Direct medical cost of overweight and obesity in the USA: a quantitative systematic review. Obes Rev. 2011;12(1):50–61. doi:10.1111/j.1467-789X.2009.00708.x
52. Tremmel M, Gerdtham UG, Nilsson PM, Saha S. Economic Burden of Obesity: A Systematic Literature Review. Int J Environ Res Public Health. 2017;14(4):435. Published 2017 Apr 19. doi:10.3390/ijerph14040435
53. Furlong M, Deming-Halverson S, Sandler DP. Chronic antibiotic use during adulthood and weight change in the Sister Study. PLoS One. 2019;14(5):e0216959. Published 2019 May 16. doi:10.1371/journal.pone.0216959
54. Hsu PC, Chen SJ. Obesity and risk of urinary tract infection in young children presenting with fever. Medicine (Baltimore). 2018;97(49):e13006. doi:10.1097/MD.0000000000013006
55. Semins MJ, Shore AD, Makary MA, Weiner J, Matlaga BR. The impact of obesity on urinary tract infection risk. Urology. 2012 Feb;79(2):266-9. doi: 10.1016/j.urology.2011.09.040.
56. Gaither TW, Cooper CS, Kornberg Z, Baskin LS, Copp HL. Predictors of becoming overweight among pediatric patients at risk for urinary tract infections. J Pediatr Urol. 2019 Feb;15(1):61.e1-61.e6. doi: 10.1016/j.jpurol.2018.09.002.
57. Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metabolism. 2019 Mar;92:6-10. doi: 10.1016/j.metabol.2018.09.005.
58. Nseir W, Farah R, Mahamid M, Sayed-Ahmad H, Mograbi J, Taha M, Artul S. Obesity and recurrent urinary tract infections in premenopausal women: a retrospective study. Int J Infect Dis. 2015 Dec;41:32-5. doi: 10.1016/j.ijid.2015.10.014.
59. Rodríguez-Cerdeira C, Cordeiro-Rodríguez M, Carnero-Gregorio M, et al. Biomarkers of Inflammation in Obesity-Psoriatic Patients. Mediators Inflamm. 2019;2019:7353420. Published 2019 May 28. doi:10.1155/2019/7353420
60. Jung J-H, Hong HJ, Gharderpour A, et al. Differential interleukin-1β induction by uropathogenic Escherichia coli correlates with its phylotype and serum C-reactive protein levels in Korean infants. Scientific Reports. 2019;9(1). doi:10.1038/s41598-019-52070-3.
61. Baldani DP, Skrgatic L, Kasum M, Zlopasa G, Kralik Oguic S, Herman M. Altered leptin, adiponectin, resistin and ghrelin secretion may represent an intrinsic polycystic ovary syndrome abnormality. Gynecol Endocrinol. 2019 May;35(5):401-405. doi: 10.1080/09513590.2018.1534096.
62. Kennelly M, Thiruchelvam N, Averbeck MA, et al. Adult Neurogenic Lower Urinary Tract Dysfunction and Intermittent Catheterisation in a Community Setting: Risk Factors Model for Urinary Tract Infections. Adv Urol. 2019;2019:2757862. Published 2019 Apr 2. doi:10.1155/2019/2757862
63. Carbone A, Al Salhi Y, Tasca A, Palleschi G, Fuschi A, De Nunzio C, Bozzini G, Mazzaferro S, Pastore AL. Obesity and kidney stone disease: a systematic review. Minerva Urol Nefrol. 2018 Aug;70(4):393-400. doi: 10.23736/S0393-2249.18.03113-2.
64. Shetty A, Syn WK. Health and Economic Burden of Nonalcoholic Fatty Liver Disease in the United States and Its Impact on Veterans. Fed Pract. 2019;36(1):14–19.
65. Younossi ZM, Blissett D, Blissett R, Henry L, Stepanova M, Younossi Y, Racila A, Hunt S, Beckerman R. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology. 2016 Nov;64(5):1577-1586. doi: 10.1002/hep.28785.
66. Dokmak A, Almeqdadi M, Trivedi H, Krishnan S. Rise of sodium-glucose cotransporter 2 inhibitors in the management of nonalcoholic fatty liver disease. World J Hepatol. 2019;11(7):562–573. doi:10.4254/wjh.v11.i7.562
67. Nseir W, Amara A, Farah R, Ahmad HS, Mograbi J, Mahamid M. Non-alcoholic Fatty Liver Disease is Associated with Recurrent Urinary Tract Infection in Premenopausal Women Independent of Metabolic Syndrome. Isr Med Assoc J. 2019 Jun;21(6):386-389.
68. Song YA, Kwon SS, Doo SW, Kim JH, Yang WJ, Song YS. Is There Any Relation Between the Degree of Fatty Liver Disease and Severity of Lower Urinary Tract Symptoms? Urology. 2016 Mar;89:90-5. doi: 10.1016/j.urology.2015.11.030.
69. Kim KS, Lee BW, Kim YJ, Lee DH, Cha BS, Park CY. Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment. Diabetes Metab J. 2019;43(2):127–143. doi:10.4093/dmj.2019.0034
70. Raj H, Durgia H, Palui R, et al. SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A systematic review. World J Diabetes. 2019;10(2):114–132. doi:10.4239/wjd.v10.i2.114
71. Tentolouris A, Vlachakis P, Tzeravini E, Eleftheriadou I, Tentolouris N. SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects. Int J Environ Res Public Health. 2019;16(16):2965. Published 2019 Aug 17. doi:10.3390/ijerph16162965
72. Nagahisa T, Saisho Y. Cardiorenal Protection: Potential of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes. Diabetes Ther. 2019;10(5):1733–1752. doi:10.1007/s13300-019-00680-5
73. Lega IC, Bronskill SE, Campitelli MA, Guan J, Stall NM, Lam K, McCarthy LM, Gruneir A, Rochon PA. Sodium glucose cotransporter 2 inhibitors and risk of genital mycotic and urinary tract infection: A population-based study of older women and men with diabetes. Diabetes Obes Metab. 2019 Nov;21(11):2394-2404. doi: 10.1111/dom.13820.
74. Méndez-Sánchez N, Zamarripa-Dorsey F, Panduro A, et al. Current trends of liver cirrhosis in Mexico: Similitudes and differences with other world regions. World J Clin Cases. 2018;6(15):922–930. doi:10.12998/wjcc.v6.i15.922
75. Stasi C, Silvestri C, Voller F, Cipriani F. Epidemiology of Liver Cirrhosis. J Clin Exp Hepatol. 2015;5(3):272. doi:10.1016/j.jceh.2015.06.002
76. Reuken PA, Stallmach A, Bruns T. Mortality after urinary tract infections in patients with advanced cirrhosis – Relevance of acute kidney injury and comorbidities. Liver Int. 2013 Feb;33(2):220-30. doi: 10.1111/liv.12029.
77. Lameirão Gomes C, Violante Silva R, Carrola P, Presa J. Bacterial Infections in Patients with Liver Cirrhosis in an Internal Medicine Department. GE Port J Gastroenterol. 2019;26(5):324–332. doi:10.1159/000494568
78. Milovanovic T, Dumic I, Veličkovic J, Lalosevic MS, Nikolic V, Palibrk I. Epidemiology and risk factors for multi-drug resistant hospital-acquired urinary tract infection in patients with liver cirrhosis: single center experience in Serbia. BMC Infect Dis. 2019;19(1):141. Published 2019 Feb 12. doi:10.1186/s12879-019-3761-5
79. Varyani FK, West J, Card TR. Primary biliary cirrhosis does not increase the risk of UTIs following diagnosis compared to other chronic liver diseases? Liver Int. 2013 Mar;33(3):384-8. doi: 10.1111/liv.12107.
80. Park JY, Ko KO, Lim JW, Cheon EJ, Yoon JM. Increase in Aminotransferase Levels during Urinary Tract Infections in Children. Pediatr Gastroenterol Hepatol Nutr. 2013;16(2):89–94. doi:10.5223/pghn.2013.16.2.89
81. Søholm J, Holm DK, Mössner B, et al. Incidence, prevalence and risk factors for hepatitis C in Danish prisons. PLoS One. 2019;14(7):e0220297. Published 2019 Jul 26. doi:10.1371/journal.pone.0220297
82. Mohammadzadeh M, Derafshi H, Ghari T. The Estimation of Economic Burden of Hepatitis C Virus Infection in Iran. Iran J Public Health. 2018;47(10):1575–1582.
83. Basit H, Tyagi I, Koirala J. Hepatitis C. [Updated 2019 May 15]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430897/
84. Edmunds BL, Miller ER, Tsourtos G. The distribution and socioeconomic burden of Hepatitis C virus in South Australia: a cross-sectional study 2010-2016. BMC Public Health. 2019;19(1):527. Published 2019 May 8. doi:10.1186/s12889-019-6847-5
85. Cruz Rde C, Tanajura D, Almeida D, Cruz M, Paraná R. Urinary tract infection in non-hospitalized patients with cirrhosis and no symptoms of urinary tract infection: a case series study. Braz J Infect Dis. 2006 Dec;10(6):380-3.
86. Mohiuddin AK. Drug Addiction in Bangladesh: “A Consequence of Social Demoralization Rather Than Individual Flaws.” International Journal of Addiction Research and Therapy. 2019. doi:10.28933/ijart-2019-11-1005.
87. Witkiewitz K, Vowles KE. Alcohol and Opioid Use, Co-Use, and Chronic Pain in the Context of the Opioid Epidemic: A Critical Review. Alcohol Clin Exp Res. 2018;42(3):478–488. doi:10.1111/acer.13594
88. Sacks JJ, Gonzales KR, Bouchery EE, Tomedi LE, Brewer RD. 2010 National and State Costs of Excessive Alcohol Consumption. Am J Prev Med. 2015 Nov;49(5):e73-e79. doi: 10.1016/j.amepre.2015.05.031.
89. Pitts TO, Van Thiel DH. Urinary tract infections and renal papillary necrosis in alcoholism. Recent Dev Alcohol. 1986;4:341-55.
90. Villines Z. What to know about kidney pain after drinking alcohol? (Medically reviewed by Carissa Stephens, R.N., CCRN, CPN). MedicalNewsToday, August 27, 2019.
91. Polhuis KCMM, Wijnen AHC, Sierksma A, Calame W, Tieland M. The Diuretic Action of Weak and Strong Alcoholic Beverages in Elderly Men: A Randomized Diet-Controlled Crossover Trial. Nutrients. 2017;9(7):660. Published 2017 Jun 28. doi:10.3390/nu9070660
92. Lean K, Nawaz RF, Jawad S, Vincent C. Reducing urinary tract infections in care homes by improving hydration. BMJ Open Qual. 2019;8(3):e000563. Published 2019 Jul 10. doi:10.1136/bmjoq-2018-000563
93. Wit MD, Goldberg A, Chelmow D. Alcohol Use Disorders and Hospital-Acquired Infections in Women Undergoing Cesarean Delivery. Obstetrics & Gynecology. 2013;122(1):72-78. doi:10.1097/aog.0b013e318297be8d.
94. Sander M, Neumann T, Dossow VV, Schönfeld H, Lau A, Eggers V, Spies C. Alkoholabusus. Der Internist. 2006;47(4):332-341. doi:10.1007/s00108-006-1588-9.
95. Sobotová D. Urinary tract infections and chronic renal failure. Vnitr Lek 2011;57:626-30.
96. Tandogdu Z, Cai T, Koves B, Wagenlehner F, Bjerklund-Johansen TE. Urinary Tract Infections in Immunocompromised Patients with Diabetes, Chronic Kidney Disease, and Kidney Transplant. European Urology Focus. 2016;2(4):394-399. doi:10.1016/j.euf.2016.08.006.
97. Ozieh MN, Bishu KG, Dismuke CE, Egede LE. Trends in healthcare expenditure in United States adults with chronic kidney disease: 2002-2011. BMC Health Serv Res. 2017;17(1):368. Published 2017 May 22. doi:10.1186/s12913-017-2303-3
98. Manns B, Hemmelgarn B, Tonelli M, et al. The Cost of Care for People With Chronic Kidney Disease. Can J Kidney Health Dis. 2019;6:2054358119835521. Published 2019 Apr 4. doi:10.1177/2054358119835521
99. Saran R, Robinson B, Abbott KC, et al. US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2019;73(3S1):A7–A8. doi:10.1053/j.ajkd.2019.01.001
100. Jayasinghe K, Quinlan C, Stark Z, et al. Renal genetics in Australia: Kidney medicine in the genomic age. Nephrology (Carlton). 2019;24(3):279–286. doi:10.1111/nep.13494
101. Lv JC, Zhang LX. Prevalence and Disease Burden of Chronic Kidney Disease. Adv Exp Med Biol. 2019;1165:3-15. doi: 10.1007/978-981-13-8871-2_1.
102. Ahmed H, Farewell D, Francis NA, Paranjothy S, Butler CC. Risk of adverse outcomes following urinary tract infection in older people with renal impairment: Retrospective cohort study using linked health record data. PLoS Med. 2018;15(9):e1002652. Published 2018 Sep 10. doi:10.1371/journal.pmed.1002652
103. Hsiao CY, Lin HL, Lin YK, Chen CW, Cheng YC, Lee WC, Wu TC. Urinary tract infection in patients with chronic kidney disease. Turk J Med Sci. 2014;44(1):145-9.
104. Gilbert DN. Urinary tract infections in patients with chronic renal insufficiency. Clin J Am Soc Nephrol. 2006 Mar;1(2):327-31.
105. McDonald HI, Thomas SL, Nitsch D. Chronic kidney disease as a risk factor for acute community-acquired infections in high-income countries: a systematic review. BMJ Open. 2014;4(4):e004100. Published 2014 Apr 17. doi:10.1136/bmjopen-2013-004100
106. Letica-Kriegel AS, Salmasian H, Vawdrey DK, et al. Identifying the risk factors for catheter-associated urinary tract infections: a large cross-sectional study of six hospitals. BMJ Open. 2019;9(2):e022137. Published 2019 Feb 21. doi:10.1136/bmjopen-2018-022137
107. Storme O, Tirán Saucedo J, Garcia-Mora A, Dehesa-Dávila M, Naber KG. Risk factors and predisposing conditions for urinary tract infection. Ther Adv Urol. 2019;11:1756287218814382. Published 2019 May 2. doi:10.1177/1756287218814382
108. Fasugba O, Cheng AC, Gregory V, et al. Chlorhexidine for meatal cleaning in reducing catheter-associated urinary tract infections: a multicentre stepped-wedge randomised controlled trial. The Lancet Infectious Diseases. 2019;19(6):611-619. doi:10.1016/s1473-3099(18)30736-9.
109. Jahromi MS, Mure A, Gomez CS. UTIs in patients with neurogenic bladder. Curr Urol Rep. 2014 Sep;15(9):433. doi: 10.1007/s11934-014-0433-2.
110. Lorenzo Gómez MF, Collazos Robles RE, Virseda Rodríguez ÁJ, García Cenador MB, Mirón Canelo JA, Padilla Fernández B. Urinary tract infections in women with stress urinary incontinence treated with transobturator suburethral tape and benefit gained from the sublingual polibacterial vaccine. Ther Adv Urol. 2015;7(4):180–185. doi:10.1177/1756287215576648
111. Sanaee MS, Hutcheon JA, Larouche M, Brown HL, Lee T, Geoffrion R. Urinary tract infection prevention after midurethral slings in pelvic floor reconstructive surgery: A systematic review and meta‐analysis. Acta Obstetricia et Gynecologica Scandinavica. 2019;98(12):1514-1522. doi:10.1111/aogs.13661.
112. Hamid R, Losco G. Pelvic Organ Prolapse-Associated Cystitis. Curr Bladder Dysfunct Rep. 2014;9(3):175–180. doi:10.1007/s11884-014-0249-4
113. Brown KA, Chambers A, MacFarlane S, et al. Reducing unnecessary urine culturing and antibiotic overprescribing in long-term care: a before-and-after analysis. CMAJ Open. 2019;7(1):E174–E181. Published 2019 Mar 29. doi:10.9778/cmajo.20180064
114. Nicolle LE, Yoshikawa TT. Urinary Tract Infection in Long-Term-Care Facility Residents. Clinical Infectious Diseases. 2000;31(3):757-761. doi:10.1086/313996.
115. Genao L, Buhr GT. Urinary Tract Infections in Older Adults Residing in Long-Term Care Facilities. Ann Longterm Care. 2012;20(4):33–38.
116. Mody L, Meddings J, Edson BS, et al. Enhancing Resident Safety by Preventing Healthcare-Associated Infection: A National Initiative to Reduce Catheter-Associated Urinary Tract Infections in Nursing Homes. Clin Infect Dis. 2015;61(1):86–94. doi:10.1093/cid/civ236
117. Mody L, Krein SL, Saint S, Min LC, Montoya A, Lansing B, McNamara SE, Symons K, Fisch J, Koo E, Rye RA, Galecki A, Kabeto MU, Fitzgerald JT, Olmsted RN, Kauffman CA, Bradley SF. A targeted infection prevention intervention in nursing home residents with indwelling devices: a randomized clinical trial. JAMA Intern Med. 2015 May;175(5):714-23. doi: 10.1001/jamainternmed.2015.132.
118. Marami D, Balakrishnan S, Seyoum B. Prevalence, Antimicrobial Susceptibility Pattern of Bacterial Isolates, and Associated Factors of Urinary Tract Infections among HIV-Positive Patients at Hiwot Fana Specialized University Hospital, Eastern Ethiopia. Can J Infect Dis Med Microbiol. 2019;2019:6780354. Published 2019 Feb 6. doi:10.1155/2019/6780354
119. Shannon CL, Klausner JD. The growing epidemic of sexually transmitted infections in adolescents: a neglected population. Curr Opin Pediatr. 2018;30(1):137–143. doi:10.1097/MOP.0000000000000578
120. Rowley J, Vander Hoorn S, Korenromp E, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019;97(8):548–562P. doi:10.2471/BLT.18.228486
121. Shipman SB, Risinger CR, Evans CM, Gilbertson CD, Hogan DE. High Prevalence of Sterile Pyuria in the Setting of Sexually Transmitted Infection in Women Presenting to an Emergency Department. West J Emerg Med. 2018;19(2):282–286. doi:10.5811/westjem.2017.12.35605
122. Mancino P, Dalessandro M, Falasca K, Ucciferri C, Pizzigallo E, Vecchiet J. Acute urinary retention due to HSV-1: a case report. Infez Med. 2009 Mar;17(1):38-40.
123. Yamanishi T, Yasuda K, Sakakibara R, et al. Urinary retention due to herpes virus infections. Neurourology and Urodynamics. 1998;17(6):613-619. https://doi.org/10.1002/(SICI)1520-6777(1998)17:6<613::AID-NAU5>3.0.CO;2-2
124. Azami M, Jaafari Z, Masoumi M, et al. The etiology and prevalence of urinary tract infection and asymptomatic bacteriuria in pregnant women in Iran: a systematic review and Meta-analysis. BMC Urol. 2019;19(1):43. Published 2019 May 30. doi:10.1186/s12894-019-0454-8
125. Gilstrap LC 3rd, Ramin SM. Urinary tract infections during pregnancy. Obstet Gynecol Clin North Am. 2001 Sep;28(3):581-91.
126. Amiri M, Lavasani Z, Norouzirad R, et al. Prevalence of Urinary Tract Infection Among Pregnant Women and its Complications in Their Newborns During the Birth in the Hospitals of Dezful City, Iran, 2012 – 2013. Iran Red Crescent Med J. 2015;17(8):e26946. Published 2015 Aug 24. doi:10.5812/ircmj.26946
127. Ghouri F, Hollywood A, Ryan K. Urinary tract infections and antibiotic use in pregnancy – qualitative analysis of online forum content. BMC Pregnancy Childbirth. 2019;19(1):289. Published 2019 Aug 13. doi:10.1186/s12884-019-2451-z
128. Parikh P, Bhat V. Urinary tract infection in cancer patients in a tertiary cancer setting in India: microbial spectrum and antibiotic susceptibility pattern. Antimicrob Resist Infect Control. 2015;4(Suppl 1):P221. Published 2015 Jun 16. doi:10.1186/2047-2994-4-S1-P221
129. Nik-Ahd F, Lenore Ackerman A, Anger J. Recurrent Urinary Tract Infections in Females and the Overlap with Overactive Bladder. Curr Urol Rep. 2018 Sep 13;19(11):94. doi: 10.1007/s11934-018-0839-3.
130. Jhang JF, Kuo HC. Recent advances in recurrent urinary tract infection from pathogenesis and biomarkers to prevention. Ci Ji Yi Xue Za Zhi. 2017;29(3):131–137. doi:10.4103/tcmj.tcmj_53_17
131. Huang CH, Chou YH, Yeh HW, Huang JY, Yang SF, Yeh CB. Risk of Cancer after Lower Urinary Tract Infection: A Population-Based Cohort Study. Int J Environ Res Public Health. 2019;16(3):390. Published 2019 Jan 30. doi:10.3390/ijerph16030390
132. Glover M, Moreira CG, Sperandio V, Zimmern P. Recurrent urinary tract infections in healthy and nonpregnant women. Urol Sci. 2014;25(1):1–8. doi:10.1016/j.urols.2013.11.007
133. Al-Badr A, Al-Shaikh G. Recurrent Urinary Tract Infections Management in Women: A review. Sultan Qaboos Univ Med J. 2013;13(3):359–367. doi:10.12816/0003256
134. Alvisi S, Gava G, Orsili I, et al. Vaginal Health in Menopausal Women. Medicina (Kaunas). 2019;55(10):615. Published 2019 Sep 20. doi:10.3390/medicina55100615
135. Abou Heidar NF, Degheili JA, Yacoubian AA, Khauli RB. Management of urinary tract infection in women: A practical approach for everyday practice. Urol Ann. 2019;11(4):339–346. doi:10.4103/UA.UA_104_19
136. Jung C, Brubaker L. The etiology and management of recurrent urinary tract infections in postmenopausal women. Climacteric. 2019 Jun;22(3):242-249. doi: 10.1080/13697137.2018.1551871.